Mel-Mont Medical, LLC announces the development of Mía by XytoTest®, a self-collected cervical sample that seeks to eradicate cervical cancer
Friday, 28 July 2017
Mía by XytoTest® is a preventive comprehensive diagnostic system developed and patented by the American company, Mel-Mont Medical, LLC founded in 2014 by Frank Meléndez, MSc. and Liliana Montes, MSc. both medical device developers. This innovative system includes a medical device that allows women to self-collect cervical cells in any environment without assistance, to later
- Published in Health & life sciences
No Comments